Operating Expenses Summary of Immuron Limited

Immuron Limited's latest annual operating expenses in 2024 was 9.13 Million AUD , up 25.01% from previous year.
Immuron Limited's latest quarterly operating expenses in 2024 FY was 11.96 Million AUD , up 63.63% from previous quarter.
Immuron Limited reported a annual operating expenses of 7.3 Million AUD in annual operating expenses 2023, up 59.5% from previous year.
Immuron Limited reported a annual operating expenses of 4.58 Million AUD in annual operating expenses 2022, down -46.14% from previous year.
Immuron Limited reported a quarterly operating expenses of 5.33 Million AUD for 2024 Q2, down 0.0% from previous quarter.
Immuron Limited reported a quarterly operating expenses of 5.53 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Immuron Limited (2024 - 1999)

Historical Annual Operating Expenses of Immuron Limited (2024 - 1999)

Year	Operating Expenses	Operating Expenses Growth
2024	9.13 Million AUD	25.01%
2023	7.3 Million AUD	59.5%
2022	4.58 Million AUD	-46.14%
2021	8.5 Million AUD	63.0%
2020	5.22 Million AUD	-17.96%
2019	6.36 Million AUD	49.77%
2018	4.24 Million AUD	-44.9%
2017	7.71 Million AUD	3.7%
2016	7.43 Million AUD	115.18%
2015	3.45 Million AUD	24.62%
2014	2.77 Million AUD	186.71%
2013	-3.19 Million AUD	5.62%
2012	-3.38 Million AUD	-17.38%
2011	-2.88 Million AUD	-17.77%
2010	-2.45 Million AUD	26.21%
2009	-3.32 Million AUD	17.25%
2008	-4.01 Million AUD	20.04%
2007	-5.02 Million AUD	13.39%
2006	-5.79 Million AUD	-1542.08%
2005	-352.97 Thousand AUD	89.69%
2004	-3.42 Million AUD	0.0%
2003	- AUD	100.0%
2002	-2.52 Million AUD	-58.52%
2001	-1.59 Million AUD	0.0%
2000	- AUD	0.0%
1999	- AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 FY	11.96 Million AUD	63.63%
2024 Q2	5.33 Million AUD	0.0%
2024 Q4	5.53 Million AUD	0.0%
2023 FY	7.3 Million AUD	59.5%
2023 Q2	3.84 Million AUD	0.0%
2023 Q4	3.46 Million AUD	0.0%
2022 Q4	2.09 Million AUD	0.0%
2022 Q2	2.5 Million AUD	0.0%
2022 FY	4.58 Million AUD	-46.14%
2021 Q2	5.41 Million AUD	0.0%
2021 FY	8.5 Million AUD	63.0%
2021 Q4	3.09 Million AUD	0.0%
2020 Q2	3.71 Million AUD	0.0%
2020 FY	5.22 Million AUD	-17.96%
2020 Q4	2.27 Million AUD	0.0%
2019 FY	6.36 Million AUD	49.77%
2019 Q4	4.29 Million AUD	0.0%
2019 Q2	2.32 Million AUD	0.0%
2018 Q4	1.8 Million AUD	0.0%
2018 Q2	2.44 Million AUD	0.0%
2018 FY	4.24 Million AUD	-44.9%
2017 Q4	3.96 Million AUD	0.0%
2017 FY	7.71 Million AUD	3.7%
2017 Q2	3.74 Million AUD	0.0%
2016 Q4	2.54 Million AUD	0.0%
2016 Q2	3.41 Million AUD	0.0%
2016 FY	7.43 Million AUD	115.18%
2015 Q4	1.73 Million AUD	0.0%
2015 Q2	1.72 Million AUD	0.0%
2015 FY	3.45 Million AUD	24.62%
2014 Q2	1.7 Million AUD	0.0%
2014 FY	2.77 Million AUD	186.71%
2014 Q4	1.05 Million AUD	0.0%
2013 Q3	799.42 Thousand AUD	-43.91%
2013 FY	-3.19 Million AUD	5.62%
2013 Q1	847.06 Thousand AUD	0.0%
2013 Q4	1.9 Million AUD	138.02%
2013 Q2	1.42 Million AUD	68.25%
2012 Q1	721.64 Thousand AUD	0.0%
2012 FY	-3.38 Million AUD	-17.38%
2012 Q4	847.06 Thousand AUD	0.0%
2012 Q3	847.06 Thousand AUD	0.0%
2012 Q2	847.06 Thousand AUD	17.38%
2011 Q3	721.64 Thousand AUD	0.0%
2011 Q4	721.64 Thousand AUD	0.0%
2011 FY	-2.88 Million AUD	-17.77%
2011 Q2	721.64 Thousand AUD	17.78%
2011 Q1	612.73 Thousand AUD	0.0%
2010 Q3	612.73 Thousand AUD	0.0%
2010 FY	-2.45 Million AUD	26.21%
2010 Q4	612.73 Thousand AUD	0.0%
2010 Q2	612.73 Thousand AUD	-26.21%
2010 Q1	830.41 Thousand AUD	0.0%
2009 FY	-3.32 Million AUD	17.25%
2009 Q1	1 Million AUD	0.0%
2009 Q2	830.41 Thousand AUD	-17.25%
2009 Q3	830.41 Thousand AUD	0.0%
2009 Q4	830.41 Thousand AUD	0.0%
2008 Q1	1.25 Million AUD	0.0%
2008 Q2	1 Million AUD	-20.04%
2008 FY	-4.01 Million AUD	20.04%
2008 Q4	1 Million AUD	0.0%
2008 Q3	1 Million AUD	0.0%
2007 Q1	1.44 Million AUD	0.0%
2007 FY	-5.02 Million AUD	13.39%
2007 Q2	1.25 Million AUD	-13.39%
2007 Q4	1.25 Million AUD	0.0%
2007 Q3	1.25 Million AUD	0.0%
2006 Q2	1.44 Million AUD	1542.09%
2006 Q1	88.24 Thousand AUD	0.0%
2006 Q4	1.44 Million AUD	0.0%
2006 Q3	1.44 Million AUD	0.0%
2006 FY	-5.79 Million AUD	-1542.08%
2005 Q2	88.24 Thousand AUD	-89.69%
2005 FY	-352.97 Thousand AUD	89.69%
2005 Q4	88.24 Thousand AUD	0.0%
2005 Q3	88.24 Thousand AUD	0.0%
2005 Q1	855.58 Thousand AUD	0.0%
2004 FY	-3.42 Million AUD	0.0%
2004 Q2	855.58 Thousand AUD	0.0%
2004 Q3	855.58 Thousand AUD	0.0%
2004 Q4	855.58 Thousand AUD	0.0%
2004 Q1	- AUD	0.0%
2003 Q1	630.82 Thousand AUD	0.0%
2003 Q2	- AUD	-100.0%
2003 Q3	- AUD	0.0%
2003 Q4	- AUD	0.0%
2003 FY	- AUD	100.0%
2002 Q1	397.94 Thousand AUD	0.0%
2002 Q4	630.82 Thousand AUD	0.0%
2002 Q3	630.82 Thousand AUD	0.0%
2002 Q2	630.82 Thousand AUD	58.52%
2002 FY	-2.52 Million AUD	-58.52%
2001 Q3	397.94 Thousand AUD	0.0%
2001 Q4	397.94 Thousand AUD	0.0%
2001 Q2	397.94 Thousand AUD	0.0%
2001 Q1	- AUD	0.0%
2001 FY	-1.59 Million AUD	0.0%
2000 Q1	- AUD	0.0%
2000 FY	- AUD	0.0%
2000 Q4	- AUD	0.0%
2000 Q3	- AUD	0.0%
2000 Q2	- AUD	0.0%
1999 Q2	- AUD	0.0%
1999 Q3	- AUD	0.0%
1999 Q4	- AUD	0.0%
1999 FY	- AUD	0.0%

Peer Operating Expenses Comparison of Immuron Limited

Name	Operating Expenses	Operating Expenses Difference
AdAlta Limited	6.76 Million AUD	-34.986%
Acrux Limited	8.55 Million AUD	-6.876%
Actinogen Medical Limited	22.77 Million AUD	59.869%
AnteoTech Limited	12.18 Million AUD	25.019%
Argenica Therapeutics Limited	8.26 Million AUD	-10.506%
Arovella Therapeutics Limited	10.78 Million AUD	15.274%
Anatara Lifesciences Ltd	710.21 Thousand AUD	-1186.637%
Alterity Therapeutics Limited	23.4 Million AUD	60.96%
Amplia Therapeutics Limited	8.43 Million AUD	-8.324%
Avecho Biotechnology Limited	4.54 Million AUD	-101.037%
Bio-Gene Technology Limited	2.76 Million AUD	-230.962%
Biome Australia Limited	7.91 Million AUD	-15.506%
Biotron Limited	5.11 Million AUD	-78.801%
Botanix Pharmaceuticals Limited	601.82 Thousand AUD	-1418.38%
BTC Health Limited	-1.03 Million AUD	979.553%
Chimeric Therapeutics Limited	19.76 Million AUD	53.773%
CSL Limited	7.56 Billion AUD	99.879%
Clarity Pharmaceuticals Ltd	56.3 Million AUD	83.771%
Clinuvel Pharmaceuticals Limited	31.29 Million AUD	70.803%
Cynata Therapeutics Limited	11.12 Million AUD	17.851%
Dimerix Limited	25.64 Million AUD	64.365%
EZZ Life Science Holdings Limited	39.57 Million AUD	76.91%
Hexima Limited	1 Million AUD	-805.865%
Island Pharmaceuticals Limited	4.12 Million AUD	-121.506%
Immutep Limited	42.87 Million AUD	78.687%
Imugene Limited	135.09 Million AUD	93.236%
Invex Therapeutics Ltd	3.34 Million AUD	-173.109%
Memphasys Limited	3.67 Million AUD	-148.422%
Nanollose Limited	12.5 Thousand AUD	-72997.472%
Neuren Pharmaceuticals Limited	32.69 Million AUD	72.053%
Noxopharm Limited	7 Million AUD	-30.538%
NeuroScientific Biopharmaceuticals Limited	1.96 Million AUD	-364.982%
Nyrada Inc.	4.55 Million AUD	-100.605%
Orthocell Limited	15.36 Million AUD	40.545%
PharmAust Limited	6.65 Million AUD	-37.268%
Patrys Limited	4.93 Million AUD	-85.229%
Paradigm Biopharmaceuticals Limited	65.1 Million AUD	85.964%
Proteomics International Laboratories Limited	892.14 Thousand AUD	-924.266%
Prescient Therapeutics Limited	10.89 Million AUD	16.157%
PYC Therapeutics Limited	60.91 Million AUD	84.999%
Race Oncology Limited	14.77 Million AUD	38.134%
Radiopharm Theranostics Limited	299.22 Thousand AUD	-2953.83%
Recce Pharmaceuticals Ltd	21.68 Million AUD	57.86%
Starpharma Holdings Limited	22.81 Million AUD	59.95%
Telix Pharmaceuticals Limited	269.26 Million AUD	96.606%
Tissue Repair Ltd	6.66 Million AUD	-37.066%
Zelira Therapeutics Limited	5.94 Million AUD	-53.617%

Global Stocks Search

Immuron Limited (IMC.AX)

Operating Expenses Summary of Immuron Limited

Annual Operating Expenses Chart of Immuron Limited (2024 - 1999)

Historical Annual Operating Expenses of Immuron Limited (2024 - 1999)

Peer Operating Expenses Comparison of Immuron Limited